Background
Developing countries are currently undergoing one of the most rapid epidemiological transitions due to urbanization and changing lifestyles that are associated with the increasing occurrence of diabetes mellitus (DM). 1 It is a well-known fact that diabetic patients can live longer with diabetes and that the occurrence of chronic complications that lead to deterioration of the patients' quality of life and even death can be much delayed through access to comprehensive medical care and achieving a sustained level of good glycemic control. 2 The proper use of effective medications over a sustained period and a recommended change of lifestyle have been shown to be crucial for the success of glycemic control in the management of DM. 3 Adequate diabetes care has a wider and more comprehensive scope than merely aiming for glycemic control; it also aims at preventing and treating life-threatening end organ damage due to DM. By doing so, adequate diabetes care can prevent premature death. 4 However, in routine clinical practice in developing countries, it is very challenging not only to manage end organ damage due to DM but also to achieve sustained glycemic control. 3 Studies have shown that sustained poor glycemic control as defined by glycosylated hemoglobin level (HbA 1c ) $7% is a major risk factor for the occurrence of DM-related chronic complications. And HbA 1c is a simple blood test that provides useful information on the average blood glucose control over a 6-to-12-week period. 3, [5] [6] [7] Despite the fact that DM is believed to be an emerging and huge health care challenge in developing countries, very little has been studied about the Ethiopian situation to help policy makers and stakeholders initiate evidence-based planning and suitable interventions to combat DM. We conducted a cross-sectional study to assess the level of glycemic control and its associated factors among DM patients receiving diabetes care at the University of Gondar Referral Hospital.
Methods
A hospital-based cross-sectional design was used for the study. The hospital has a Diabetes Illness Follow-up Care Clinic, which was organized 2 decades ago and currently provides free service for more than 8,000 diabetic patients on a follow-up basis. We chose the 2-month follow-up schedule for data collection to avoid repetition of the cases as patients revisit the clinic every 2 months.
Study population
All diabetic patients aged $18 years who visited the Clinic in January and February 2013 for control of blood sugar and medication were invited to participate in the study. Also, patients who were on follow-up for $12 months were included in the study as adequate time was needed for assessing adherence. On the other hand, those who were critically ill and unable to participate in the interview and also those who were recently diagnosed and had a follow-up of ,12 months were excluded. About 1,000 diabetic patients visited the Clinic in the 2 month period. Every second person aged $18 years was included. Thus, a total of 407 study subjects were selected through a systematic sampling procedure.
Data collection
Data were collected by interviewing eligible participants using a pretested and structured questionnaire. Patients were given an orientation on the protocol and specific details concerning participation in the study. The questionnaire, which was in the local language (Amharic), included questions that assessed diabetes-related factors (background information, lifestyle factors, clinical history, and medication adherence using the eight-item Morisky medication adherence scale ). 3, 4 Anthropometric measurements were taken using standardized techniques and calibrated equipment. Patients were weighed to the nearest 0.1 kg in light indoor clothing and bare feet or with stockings. Height was measured using a stadiometer; waist girth was measured by placing a plastic tape to the nearest 0.5 cm horizontally, midway between the 12th rib and the iliac crest on the midaxillary line. Hip circumference was measured around the widest portion of the buttocks, with the tape parallel to the floor. Finally, biochemical tests (HbA 1c , FBG, triglyceride, and total cholesterol test) were carried out. 5 Blood samples were collected from each participant by a trained laboratory technician following aseptic techniques. The blood samples were taken to the hospital laboratory for chemistry analyses immediately. Biochemical tests (HbA 1c ) were carried out using a 902 Automatic Analyzer with Roche/Hitachi kit following a minimum of 8 hours' fasting. Information about the Type 1 and Type 2 DM was collected from the hospital chart by the study nurse.
Six laboratory technicians, four nurses, and two supervisors were trained by the principal investigator. Every patient was made aware of the fasting requirement for a minimum of 8 hours prior to the lab test. A reminder was sent to them prior to the day of investigation, verbal confirmation of which was obtained prior to the blood test. The study supervisors and the principal investigator conducted regular supervisory checks to ensure data quality. Data entry and cleaning were done using Epi-info version 3.5.3.
Data analysis
Glycemic control was calculated on the basis of test results (HbA 1c $7.0%) by type of diabetes (Type 1 and 2) and stratified by residence (urban and rural). In the multivariable analysis, diabetic patients with good glycemic control (HbA 1c ,7.0%) and those with poor glycemic control (HbA 1c $7.0%) 6,7 were compared to identify potential risk factors. 
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The propensity score was used for the estimation of treatment effect of nonadherence to poor glycemic control. We stratified the analysis in terms of DM type in the multiple regressions. The results were considered statistically significant at P#0.05. Multivariable logistic regression analysis was applied to determine the associations of risk factors. The independent variables were included in the model on the basis of prior evidence in the literature and their effect in current analysis. Independent variables with a P-value of 0.20 and less, during the bivariate test, were included.
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Results
A total of 407 diabetic patients were invited to participate in this study; 16 declined to participate, yielding a response rate of 96.01% (391 out of 407). The mean age (± SD) of the persons with diabetes was 50.4 (±15.2) years. The mean age (± SD) for Type 1 DM was 35.8 (±13.4) and 56.1 (±11.5) for Type 2. There was a slight preponderance of males (53%) over females (47%). (Sociodemographic characteristics are presented in Tables 1 and 2 ).
The mean (± SD) percentage of glycated hemoglobin test (HbA 1c ) was 7.82 (±1.9) ( Table 3 ). The overall prevalence of poor glycemic control in persons with diabetes was 64.7% (95% CI =59.9, 69.4). The prevalence of poor glycemic control was significantly higher among Type 1 diabetics; the proportion with poor glycemic control was 82.9% (95% CI =75.8, 89.9) among Type 1 and 57.5% (95% CI =51.7, 63.3) among Type 2 DM patients. Poor glycemic control was higher among rural compared with urban dwellers; the proportion with poor glycemic control was 86.4% (95% CI =76.1, 96.6) and 61.9% (95% CI =56.8, 67.1) among rural and urban dwellers, respectively (Figure 1 ).
The attributable risk effect estimation of medication adherence using the propensity score showed that medication nonadherence had an effect on poor glycemic control, and the risk difference between nonadherence and good medical adherence for poor glycemic control was high among Type 2 diabetics (23.8%), (95% CI =12, 35) (t=4.14). Similarly, in Table 2 ). The reported follow-up visit for the last 6 months showed that increased frequency of hospital visits was negatively associated with poor glycemic control (AOR =0.13; 95% CI =0.03, 0.59) among persons with Type 2 diabetes. The occurrence of poor level of glycemic control was 7.6 times more likely in individuals who had no follow-up visits compared with those who had four visits in the last 6 months. Individuals receiving insulin treatment (AOR =2.51; 95% CI =1.25, 5.04) had significant association with poor glycemic control, among subjects with Type 2 DM.
Hundred and forty seven (37.7%) of the diabetic patients had a high-risk score of WC using the threshold of $92 cm for women and $104 cm for men. The multivariate logistic regression revealed that the high WC was inversely associated with poor glycemic control compared with the low WC among Type 1 persons with diabetes (AOR =0.05; 95% CI =0.01, 0.85). WC had no significant association with poor glycemic control among subjects with Type 2 DM ( Table 2 ). The duration of diabetes was also positively associated with poor glycemic control (AOR =2.17; 95% CI =1.22, 3.85). Those who had been diagnosed with DM for more than 7 years were twice as likely to have poor glycemic control as those who had diabetes for less than 7 years.
Discussion
In this study, we were able to measure objectively the proportion of poor glycemic control and its associated factors in diabetic patients. Poor glycemic control, as defined by HbA 1c $7%, was higher in persons with Type 1 diabetes, among rural dwellers, and insulin-treated Type 2 diabetics. The risk factors for poor glycemic control in Type 2 DM included poor medication adherence, being on insulin treatment, and having a poor record of follow-up visits during the last 6 months. High WC was found to be inversely associated with poor glycemic control in Type 1 DM patients. The glycemic control level found in this study was similar to a previous estimation in Africa but lower than (82.7%) that found in studies in Jimma. [10] [11] [12] The discrepancy between the findings of the study done in Jimma and those of this study can be explained by the fact that our study used the recommended test for glycemic control, the HbA 1c test, whereas the Jimma study used the fasting blood sugar (FBS) test for diagnosis. 13 Moreover, the Jimma study included only Type 1 DM patients on insulin.
The increased occurrence of poor glycemic control among Type 1 diabetics in rural parts of Ethiopia was consistent with the findings of previous studies.
11 ,14 In our study, a high level of poor glycemic control was noted among Type 2 DM patients on insulin treatment. The findings are consistent with those of other studies. 14, 15 The use of insulin among Type 2 diabetics often reflects disease severity, and it is also possible that persons with Type 2 diabetes treated with insulin are more difficult to control because of the risk of setting up a vicious cycle of increasing weight, adjusting insulin doses, and increasing insulin resistance, with consequent deterioration in glycemic control. 16, 17 In our finding, insulin-treated Type 2 diabetics were overweight (a mean BMI of 27.5 kg/m 2 ), which may contribute to the observed rise in poor glycemic levels among the insulin-treated Type 2 persons with diabetes.
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The risk difference for poor glycemic control between good treatment adherence and nonadherence was found to be high; poor glycemic control was common among those in the nonadherence group. This finding is consistent with other reports in Jordan and Malaysia. 3, 15 Literature shows that low treatment adherence continues to be a considerable barrier that prevents many diabetics from achieving good glycemic control. Increased compliance is associated with substantial improvements in glycemic control in health care. 13 The challenge of managing multiple prescriptions and a reduced sense of urgency owing to asymptomatic conditions among Type 2 DM patients, patients' understanding of their disease condition, and traditional beliefs in the rural community may affect adherence. Similarly, studies have also shown that DM patients with adequate knowledge of their status who regularly attend clinic and receive regular counseling are more likely to have better adherence. 18, 19 Continuous education is important in motivating patients to cultivate healthy lifestyles and maintain good treatment adherence. 15, 20 Besides, it is common for patients to improve their medication-taking behavior shortly before and after appointments with health care providers. 21 Our study also showed a significant association between low WC and poor level of glycemic control among Type 1 diabetic patients. One of the plausible explanations for such an association is that the strict adherence among insulintreated persons might have increased body weight and WC. Moreover, individuals who wanted to gain weight were highly likely to be adherent to treatment regimens among Type 1 DM, and this might have contributed to the observed good level of glycemic control among Type 1 DM patients with high WC compared with low WC. 22 The limitation of this research was that we used a smaller sample size in view of the high cost of HbA 1c , which affected our analysis when we stratified further in terms of diabetes type. Associated factors of poor glycemic control were hospital-based using a cross-sectional design, which might not show temporal relationships with potential risk factors. Longitudinal research is needed to assess the relationship between the variables over time.
Conclusion
The occurrence of poor levels of glycemic control was found to be higher in Type 1 DM patients, insulin-taking Type 2 DM patients, and rural dwellers. Moreover, reported nonadherence to medication regimens was common, and it substantially contributed to the poor level of glycemic control in the setting. We recommend that the health system be equipped with adequate and sustainable diagnostic tools, including the HbA 1c test for proper monitoring of glycemic control. Sustainable insulin supply for insulin-taking DM patients and a facilitated referral system for patients with complications could also help improve the situation. Stakeholders should also consider upgrading the capacity of the tertiary hospitals by providing advanced diabetes care for end organ damage that inevitably follows poor glycemic control.
